Fig 1.
Flowchart of inclusion of patients treated at FMT-HVD for skin rash.
Table 1.
Baseline and clinical characteristics of patients with rash, FMT-HVD, Manaus, February 2018 to May 2019.
Table 2.
Baseline and clinical characteristics of patients with Zika infection and other infectious causes of rash, FMT-HVD, Manaus, February 2018 to May 2019.
Fig 2.
Rash observed in patients with diagnosis for arboviruses.
(A and B) rash observed on thorax and upper limbs of ZIKV-positive patient. (C and D) peeling rash on face and lower limb edema of a CHIKV-positive patient. (E and F) rash observed on thorax, abdomen and upper limbs of a dengue-positive patient.
Table 3.
Prevalence of arboviruses and other infectious causes of rash and co-infections in patients treated at FMT-HVD, Manaus, between February 2018 to May 2019.
Fig 3.
Rashes observed in patients diagnosed with other infectious diseases in this study.
(A and B) rash observed on thorax and abdomen of an HIV-positive patient. (C and D) rash observed on thorax and upper limbs of a syphilis-positive patient. (E and F) rash observed on anterior and posterior thorax of a measles-positive patient.